The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
Long pursuit of common mutation appears to be paying off for patients and for Revolution Medicines
https://www.statnews.com/2026/04/19/daraxonrasib-pancreatic-cancer-kras-revolution-medicines-patient-story/
By Angus ChenApril 19, 2026
No hay comentarios:
Publicar un comentario